Getting sober has helped me get a grip on my mental and physical health, which go hand in hand. If you feel you are struggling ... This site contains general information about cystic fibrosis, as well ...

Hundreds of medicines have become hard or impossible to obtain as the supply crisis deepens - including drugs for pancreatic ...

The new year has just begun and with it, a new Miss America has just been crowned. The prestigious title has been earned by ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

SCOTTISH Opera is set to bring its health and arts initiative, Breath Cycle, to the stage in Greenock. The Beacon Arts Centre ...

Data has revealed the most common reasons why people lodge claims for PIP. The number one reason is psychiatric disorders.

After Covid, Polly Crosby began to pick apart her complex relationship with her chronic illness, resulting in latest novel ...

Background Newborn bloodspot screening (NBS) for cystic fibrosis (CF) was introduced across the UK in 2007 but the impact on clinical outcomes and health inequalities for children with CF is unclear.

Israeli startup Identifai develops first maternal blood test to identify risk of 250 genetic diseases as early as 9th week of ...

D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...

What is a cystic hygroma? A cystic hygroma — or lymphangioma — is a birth defect that appears as a sac-like structure with a thin wall that most commonly occurs in the head and neck area of an infant.

VIVUS will be discussing its significant 2024 momentum during the J.P. Morgan Healthcare Conference, with an emphasis on what we as a company aim to achieve during the coming months around our novel ...